These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 33579730)

  • 1. Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access.
    Richard-Greenblatt M; Comar CE; Flevaud L; Berti M; Harris RM; Weiss SR; Glaser L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33579730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
    Banada P; Elson D; Daivaa N; Park C; Desind S; Montalvan I; Kwiatkowski R; Chakravorty S; Alland D; Xie YL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34486972
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
    Banik S; Saibire K; Suryavanshi S; Johns G; Chakravorty S; Kwiatkowski R; Alland D; Banada PP
    PLoS One; 2021; 16(6):e0252687. PubMed ID: 34115762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis.
    Saini V; Kalra P; Sharma M; Rai C; Saini V; Gautam K; Bhattacharya S; Mani S; Saini K; Kumar S
    Microbiol Spectr; 2021 Dec; 9(3):e0110821. PubMed ID: 34878310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
    Banik S; Saibire K; Suryavanshi S; Johns G; Chakravorty S; Kwiatkowski R; Alland D; Banada P
    medRxiv; 2021 Jan; ():. PubMed ID: 33501462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage.
    Williams E; Isles N; Chong B; Bond K; Yoga Y; Druce J; Catton M; Ballard SA; Howden BP; Williamson DA
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33270005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
    Banada P; Elson D; Daivaa N; Park C; Desind S; Montalvan I; Kwiatkowski R; Chakravorty S; Alland D; Xie YL
    medRxiv; 2021 Mar; ():. PubMed ID: 33688680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
    Radbel J; Jagpal S; Roy J; Brooks A; Tischfield J; Sheldon M; Bixby C; Witt D; Gennaro ML; Horton DB; Barrett ES; Carson JL; Panettieri RA; Blaser MJ
    J Mol Diagn; 2020 Jul; 22(7):871-875. PubMed ID: 32405270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.
    Ngetsa C; Osoti V; Okanda D; Marura F; Shah K; Karanja H; Mugo D; Gitonga J; Mutunga M; Lewa C; Orindi B; Bejon P; Ochola-Oyier LI
    PLoS One; 2023; 18(2):e0280685. PubMed ID: 36780469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 by Use of Real-Time Reverse Transcription-PCR.
    Rogers AA; Baumann RE; Borillo GA; Kagan RM; Batterman HJ; Galdzicka MM; Marlowe EM
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32341141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of next generation diagnostic systems (NGDS) for the detection of SARS-CoV-2.
    Sanchez AO; Ochoa AR; Hall SL; Voelker CR; Mahoney RE; McDaniel JS; Blackburn A; Asin SN; Yuan TT
    J Clin Lab Anal; 2022 Apr; 36(4):e24285. PubMed ID: 35174538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dacron swab and PBS are acceptable alternatives to flocked swab and viral transport media for SARS-CoV-2.
    Kline A; Putnam NE; Youn JH; East A; Das S; Frank KM; Zelazny AM
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115209. PubMed ID: 33080426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.
    van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33114233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA.
    Mosscrop L; Watber P; Elliot P; Cooke G; Barclay W; Freemont PS; Rosadas C; Taylor GP
    J Virol Methods; 2022 Nov; 309():114607. PubMed ID: 35973468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman.
    Al-Kindi N; Al-Shukri I; Al-Rashdi A; Al-Siyabi N; Al Mahruqi S; Al-Kindi H; Al-Jardani A
    Pan Afr Med J; 2021; 40():2. PubMed ID: 34650652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?
    Federman DG; Gupta S; Stack G; Campbell SM; Peaper DR; Dembry LM; Fisher A; Tarabar AF; Kozal M; Ruser CB
    PLoS One; 2020; 15(8):e0237127. PubMed ID: 32756602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal preparation of SARS-CoV-2 viral transport medium for culture.
    McAuley J; Fraser C; Paraskeva E; Trajcevska E; Sait M; Wang N; Bert E; Purcell D; Strugnell R
    Virol J; 2021 Mar; 18(1):53. PubMed ID: 33691737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.